Pharmacokinetics of gentamicin in children with nephrotic syndrome
Author
dc.contributor.author
Gonzalez-Martin,
Author
dc.contributor.author
Bravo,
Author
dc.contributor.author
Vargas,
Author
dc.contributor.author
Arancibia,
Admission date
dc.date.accessioned
2018-12-20T15:05:08Z
Available date
dc.date.available
2018-12-20T15:05:08Z
Publication date
dc.date.issued
1986
Cita de ítem
dc.identifier.citation
International Journal of Clinical Pharmacology Therapy and Toxicology, Volumen 24, Issue 10, 2018, Pages 555-558
Identifier
dc.identifier.issn
01744879
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/157684
Abstract
dc.description.abstract
The diposition of gentamicin was studied in five children with nephrotic syndrome and five control children to observe the effect of nephrotic syndrome on the distribution and elimination of the antibiotic. After a single intravenous dose of gentamicin (2.0 mg/kg body wt.) administered to each child, blood samples were drawn at frequent intervals during a 4-h period and then analyzed by homogenous enzyme immunoassay (EMIT). Time-concentrations drug profiles were characterized by means of a two-compartment open model. The mean half-life of gentamicin in nephrotic children (96.4 ± 16.8 min) was significantly longer than in the control group (62.5 ± 7.1 min). The distribution volume of the central compartment was similar in both groups studied, but the distribution volume at steady-state was increased in children with nephrotic syndrome. Total plasma clearance was found decreased in nephrotic (2.8 ± 0.5 ml/min/kg) in comparison with controls (3.7 ± 0.7 ml/min/kg). From our findings, it co